Physician profile
Colin M Whitaker
NPI 1982053716
$3,237.27
in general payments reported to CMS, 2019-2025
11 companies · $65.97 in 2025
The $65.97 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $657 · 2021: $1,295 · 2022: $424 · 2023: $223 · 2024: $142 · 2025: $65.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321 · Entertainment: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.16 |
| Entertainment | $109.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,045.09 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $634.55 | 2019-2021 | |
| Medical Device Business Services, INC. | $466.84 | 2020-2021 | |
| Medtronic, INC. | $228.47 | 2023-2025 | Prestige LP Cervical Disc System |
| Si-Bone, INC. | $214.55 | 2021-2022 | |
| Integra Lifesciences Corporation | $207.54 | 2019 | |
| Smith+Nephew, INC. | $142.57 | 2020 | |
| Kuros Biosciences USA, INC | $109.10 | 2024 | Magnetos |
| Seaspine Orthopedics Corporation | $95.87 | 2021 | |
| Cerapedics INC. | $72.50 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Heraeus Medical, LLC. | $20.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.